APA

Moiseyev V. S., Põder P., Andrejevs N., Ruda M. Y., Golikov A. P., Lazebnik L. B., Kobalava Z. D., Lehtonen L. A., Laine T., Nieminen M. S. & Lie K. I. (20021122). Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). : European heart journal.

Chicago

Moiseyev V S, Põder P, Andrejevs N, Ruda M Y, Golikov A P, Lazebnik L B, Kobalava Z D, Lehtonen L A, Laine T, Nieminen M S and Lie K I. 20021122. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). : European heart journal.

Harvard

Moiseyev V. S., Põder P., Andrejevs N., Ruda M. Y., Golikov A. P., Lazebnik L. B., Kobalava Z. D., Lehtonen L. A., Laine T., Nieminen M. S. and Lie K. I. (20021122). Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). : European heart journal.

MLA

Moiseyev V S, Põder P, Andrejevs N, Ruda M Y, Golikov A P, Lazebnik L B, Kobalava Z D, Lehtonen L A, Laine T, Nieminen M S and Lie K I. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). : European heart journal. 20021122.